Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Required for meiotic nuclear division 1 homolog (RMND1) is a nuclear-encoded mitochondrial inner membrane protein, important for mitochondrial translation by supporting assembly or stability of the mitochondrial ribosome and facilitating translation of mtDNA-encoded proteins essential for oxidative phosphorylation. Pathogenic variants in RMND1 cause combined oxidative phosphorylation deficiency 11 (COXPD11), a severe, recessive, multisystem disorder often characterized by neonatal developmental delay, sensorineural hearing loss, renal dysfunction, cardiac involvement (especially hypertrophic cardiomyopathy), lactic acidosis, and higher mortality in early years. RMND1 mutations can also result in a Perrault-like syndrome with hearing loss, ovarian dysfunction, and chronic kidney disease, suggesting critical roles outside classic mitochondrial disease syndromes. Disease manifestations and severity depend on specific mutations, and prognosis correlates with organ involvement patterns
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Required for meiotic nuclear division 1 homolog (RMND1).